OntoChem’s has been awarded two prizes: the “IQ Innovationspreis 2013 Mitteldeutschland”, from the Life Sciences cluster and Halle city for its innovative approach “CytoPep” as a potential therapy for NPY1R related cancers such as metastatic breast cancer or Ewing sarcoma.